Compare WST & H Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | H |
|---|---|---|
| Founded | 1923 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5B | 14.6B |
| IPO Year | 2004 | 2009 |
| Metric | WST | H |
|---|---|---|
| Price | $298.02 | $165.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | ★ $325.86 | $179.53 |
| AVG Volume (30 Days) | ★ 852.0K | 699.9K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | 0.30% | ★ 0.38% |
| EPS Growth | ★ 1.49 | N/A |
| EPS | ★ 1.92 | 0.40 |
| Revenue | $2,886,900,000.00 | ★ $4,685,000,000.00 |
| Revenue This Year | $6.76 | $110.63 |
| Revenue Next Year | $6.22 | $7.01 |
| P/E Ratio | $154.77 | ★ N/A |
| Revenue Growth | 1.95 | ★ 5.78 |
| 52 Week Low | $203.74 | $120.36 |
| 52 Week High | $322.34 | $180.53 |
| Indicator | WST | H |
|---|---|---|
| Relative Strength Index (RSI) | 67.55 | 57.82 |
| Support Level | $234.43 | $137.21 |
| Resistance Level | $321.34 | $171.80 |
| Average True Range (ATR) | 8.56 | 5.31 |
| MACD | 1.56 | -0.11 |
| Stochastic Oscillator | 63.58 | 47.95 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Hyatt is an operator of owned (2% of total rooms) and managed and franchised (98%) properties across about 35 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 45% for the US, 31% rest of world, and 24% Asia-Pacific.